Modulation of ERK and JNK activity by transient forebrain ischemia in rats

被引:25
作者
Shackelford, DA [1 ]
Yeh, RY [1 ]
机构
[1] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
关键词
MAP kinase; extracellular signal-regulated kinase; c-Jun N-terminal kinase; reperfusion; cerebral ischemia;
D O I
10.1002/jnr.20747
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The mitogen-activated protein (MAP) kinase families of ERK and JNK participate in numerous intracellular signaling pathways and are abundantly expressed in the CNS. Activation of ERK and JNK during reperfusion of ischemic tissue is implicated in promoting cell death, insofar as inhibition of either pathway reduces neuronal cell death. However, ERK or JNK activation provides protection in other neuronal injury models. In this study, we monitored the concurrent modulation of ERK and JNK activity in the hippocampus, neocortex, and striatum during ischemia and immediately upon reperfusion in a rat model of transient global ischemia. All three regions incur a similar reduction in blood flow during occlusion but show different extents and temporal patterns of injury following reperfusion. ERK and JNK were active in the normal rat forebrain, and phosphorylation was reduced by ischemia. Upon reperfusion, ERK was rapidly activated in the hippocampus, neocortex, and striatum, whereas JNK phosphorylation increased in the hippocampus and striatum but not in the neocortex. The response of JNK vs. ERK more closely reflects the susceptibility of these regions. JNK1 was the predominant phosphorylated isoform. A minor pool of phosphorylated JNK3 increased above the control level after reperfusion in hippocampal but not in neocortical particulate fractions. In addition, a novel 32-35-kDa c-Jun kinase activity was detected in the hippocampus, neocortex, and striatum. The results show that ERK and JNK activities are rapidly, but not identically, modulated by ischemia and reperfusion and indicate that the MAP kinase pathways contribute to regulating the response to acute CNS injury. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:476 / 488
页数:13
相关论文
共 62 条
[1]   MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia [J].
Alessandrini, A ;
Namura, S ;
Moskowitz, MA ;
Bonventre, JV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12866-12869
[2]   Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK [J].
Allan, LA ;
Morrice, N ;
Brady, S ;
Magee, G ;
Pathak, S ;
Clarke, PR .
NATURE CELL BIOLOGY, 2003, 5 (07) :647-U45
[3]  
Behrens MM, 1999, MICROSC RES TECHNIQ, V45, P276, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<276::AID-JEMT11>3.0.CO
[4]  
2-4
[5]   A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia [J].
Borsello, T ;
Clarke, PGH ;
Hirt, L ;
Vercelli, A ;
Repici, M ;
Schorderet, DF ;
Bogousslavsky, J ;
Bonny, C .
NATURE MEDICINE, 2003, 9 (09) :1180-1186
[6]   Specific pathophysiological functions of JNK isoforms in the brain [J].
Brecht, S ;
Kirchhof, R ;
Chromik, A ;
Willesen, M ;
Nicolaus, T ;
Raivich, G ;
Wessig, J ;
Waetzig, V ;
Goetz, M ;
Claussen, M ;
Pearse, D ;
Kuan, CY ;
Vaudano, E ;
Behrens, A ;
Wagner, E ;
Flavell, RA ;
Davis, RJ ;
Herdegen, T .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 21 (02) :363-377
[7]   JNK3 contributes to c-Jun activation and apoptosis but not oxidative stress in nerve growth factor-deprived sympathetic neurons [J].
Bruckner, SR ;
Tammariello, SP ;
Kuan, CY ;
Flavell, RA ;
Rakic, P ;
Estus, S .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (02) :298-303
[8]   Synaptic plasticity in the ischaemic brain [J].
Calabresi, P ;
Centonze, D ;
Pisani, A ;
Cupini, LM ;
Bernardi, G .
LANCET NEUROLOGY, 2003, 2 (10) :622-629
[9]   Control of death receptor and mitochondrial-dependent apoptosis by c-Jun N-terminal kinase in hippocampal CA1 neurones following global transient ischaemia [J].
Carboni, S ;
Antonsson, B ;
Gaillard, P ;
Gotteland, JP ;
Gillon, JY ;
Vitte, PA .
JOURNAL OF NEUROCHEMISTRY, 2005, 92 (05) :1054-1060
[10]   AS601245 (1,3-benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4 pyrimidinyl) acetonitrile):: A c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties [J].
Carboni, S ;
Hiver, A ;
Szyndralewiez, C ;
Gaillard, P ;
Gotteland, JP ;
Vitte, PA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (01) :25-32